Measurement of key biological processes implicated in mood disorder aetiology and cognitive impairment will occur in this trial, including assessing levels of inflammatory markers (pro-inflammatory cytokines and C-Reactive Protein; CRP) [34–36], vitamin C [37, 38], and androgens (females only) [39]. The gene discussed is CRP; the disease is mood disorder.